Enhancing a Natural Killer: Modification of NK Cells for Cancer Immunotherapy

Area of Science:

• Immunology
• Oncology
• Biotechnology

Background:

• Natural killer (NK) cells are innate immune lymphocytes with potent anti-cancer activity.
• NK cells play a vital role in tumor surveillance and are a focus for adoptive immunotherapy.
• Challenges include overcoming tumor resistance and the immunosuppressive tumor microenvironment.

Purpose of the Study:

• To review strategies for enhancing NK cell-based cancer immunotherapy.
• To discuss the development of next-generation, off-the-shelf, stem cell-derived NK cell products.
• To highlight considerations for NK cell source, genetic modification, and manufacturing.

Main Methods:

• Utilizing cytokines and synthetic compounds to enhance NK cell proliferation and cytotoxic function.
• Targeting immune checkpoints to overcome tumor-induced suppression.
• Engineering NK cells with chimeric antigen receptors (CARs) for cancer specificity and ablating inhibitory receptors.

Main Results:

• Various strategies are being employed to improve NK cell number, cancer-killing capacity, and tumor microenvironment resistance.
• Next-generation NK cell therapies aim for 'off-the-shelf' availability and stem cell derivation for unlimited supply.
• Understanding NK cell biology in specific tumor contexts is key to optimizing modifications and source selection.

Conclusions:

• Advancements in NK cell biology and manufacturing are paving the way for potent, readily available immunotherapies.
• Addressing challenges in NK cell sourcing, genetic modification, and scale-up is critical for clinical translation.
• Enhanced NK cell immunotherapies are poised to become integral to multi-faceted cancer treatment strategies.